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The studies from other laboratories presented a t  this symposium indicate that 
congenital adrenal hyperplasia is a complex human disorder involving, among other 
factors, a genetic deficiency in 21-hydroxylase. This hydroxylase is one of many 
oxygenases that function in lipid transformations and are recognized from their 
biochemical properties as falling in the class of red, carbon-monoxide-binding pig- 
ments known as cytochrome P-450.' 
As judged by the reversal of CO inhibition by exposure to monochromatic light a t  
about 450 nrn, the 21-hydroxylation of 17a-hydroxyprogesterone was the first such 
steroid conversion shown to be P-450-cataly~ed.~ The 21-hydroxylase is required in the 
synthesis of adrenal corticosteroids since it catalyzes the oxygenation of A4-3- 
ketosteroids such as progesterone, as well as of 17a-hydroxyprogesterone. Like the 
17a-hydroxylase, the 21-hydroxylase is located in the endoplasmic reticulum of the 
adrenal cortex and requires NADPH-cytochrome P-450 reductase to effect electron 
transfer. The 21 -hydroxylase has been purified from bovine adrenal cortical micro- 
 some^.^^ The minimal molecular weight of the purified enzyme has been stated to 
range from 47,000 to 52,000, and P-450 specific contents as high as 20 nmol of heme 
per milligram of protein have been reported. The enzyme is apparently immunochemi- 
cally distinct from the other adrenal P-450's and contains some carbohydrate. It is 
low-spin as isolated, but can be converted to the high-spin form by the addition of 
substrate. The purified enzyme is specific for 21-hydroxylation and, unlike the 
17a-hydroxylase, shows no change in activity upon the addition of cytochrome b5.5 The 
purified preparation catalyzes the demethylation of benzphetamine at  about 30% of 
the rate of 21 -hydroxylation of 17a-hydroxyprogesterone, but is apparently inactive in 
the demethylation of p-nitroanisole or the p-hydroxylation of aniline. Of particular 
interest, the 2 1 -hydroxylase has also been purified to homogeneity from porcine 
adrenocortical microsomes, and the cysteine-containing peptides from this protein 
have been sequenced as described below.' 
In the present paper, some fundamental biochemical properties of cytochrome 
P-450 are reviewed and some implications for steroid hydroxylation are discussed. In 
particular, the known influence of environmental factors on the activities of many 
P-450's raises the question of whether some of the puzzling variables in congenital 
adrenal hyperplasia and in the function of the 21-hydroxylase are related to exposure 
to xenobiotics. 
'This work was supported by grant no. AM-10339 from the National Institutes of Health. 
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BIOCHEMISTRY OF CYTOCHROME P-450 
The active site of cytochrome P-450, as proposed previously: is pictured in FIGURE 
1. This site contains iron protoporphyrin IX, presumably in a hydrophobic cleft in the 
protein, which favors the binding of a variety of nonpolar substrates or portions of 
substrates, including physiologically occurring compounds such as steroids, prosta- 
glandins, and fatty acids. In some instances, a variety of foreign compounds, including 
drugs, carcinogens, anesthetics, pesticides, organic solvents, etc., are also accommo- 
dated by the substrate-binding site. The heme, which is not bound covalently to the 
protein, is always penta- or hexacoordinate, four of the ligands being provided by the N 
atoms of the porphyrin ring. The fifth ligand is believed to be a specific cysteine residue 
of the polypeptide chain?” and the sixth coordination position of the iron is occupied 
by an easily exchangeable oxygen ligand, perhaps from water”.’’ or the hydroxyl group 
of a serine or threonine  residue,"^.'^ in the native, ferric state of the enzyme. A tyrosine 
residue is also a likely candidate.I5*l6 Upon reduction of the iron, the sixth position 
FIGURE 1. Model of the active site of cytochrome P-450. 
becomes the site of O2 binding, but other diatomic ligands such as CO, NO, and CN- 
may compete with oxygen. Thus, CO gives the complex a n  absorption maximum a t  
about 450 nm and is inhibitory to the action of the enzyme because of the competitive 
displacement of 02. Although it would be highly desirable in all instances to name 
these enzymes by their function, as is often done with the steroid hydroxylases, some 
forms of the cytochrome have such broad substrate specificity that there is no easy way 
of choosing among the hundreds of potential substrates and the catalyst is therefore 
designated by its relative electrophoretic mobility or some other arbitrary system. 
The existence of tyrosyl and histidyl residues as well as a cysteinyl residue in the 
substrate-binding site was suggested by chemical modification s t~dies .” , ’~  In this 
connection, we have recently observed that upon the binding of the detergent CHAPS 
[3-(3-cholamidopr0pyl)-dimethylammonio- 1-propanesulfonate] to rabbit P-450 iso- 
zyme 2, a unique absorption difference spectrum is seen that is similar to that induced 
by the binding of type I1 substrates (amines). This detergent may disaggregate the 
P-450 into monomers without denaturation of the protein structure and concomitant 
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conversion of P-450 to P-420. The formation of the CHAPS-induced difference 
spectrum is slower than that caused by substrate binding, which is probably diffusion- 
controlled. Since CHAPS is not a type I1 substrate, the difference spectrum observed 
may be due to the movement of the amine moiety of some amino acid residue such as 
histidine, tryptophan, lysine, or arginine to the heme, with resulting ligation. The 
results obtained by chemical modif i~at ion '~* '~ implicate a histidyl residue. We have 
observed also that C O  binding to reduced P-450 isozyme 2 is inhibited in the presence 
of CHAPS and that the extent of this inhibition with varying detergent concentrations 
corresponds to that which would be predicted by CHAPS-induced spectral changes. 
These results strongly suggest that a conformational change occurs in the substrate- 
binding site, followed by ligation of the amine moiety (presumably of histidine) to the 
heme. 
NADPH is the primary electron donor to the cytochrome, with NADPH- 
cytochrome P-450 reductase serving as the carrier in microsornes, which is shown in 
FIGURE 2. The microsomal system, in contrast to that in mitochondria, does not utilize 
an intermediate iron-sulfur protein and, thus, makes use of direct flavin-heme electron 
transfer. The flavoprotein in this case is unusual in containing both F M N  and FAD;I9 
studies with FMN-depleted enzyme have shown that F M N  directly reduces the P-450 
heme.20 The proposed scheme in FIGURE 3 accounts for the evidence presently available 
from this and other laboratories for electron transfer and oxygen activation in this 
enzyme system. The steps, beginning with the resting ferric enzyme at  the top of the 
cycle and going clockwise, are as follows: ( 1 )  substrate binding; (2) transfer of the first 
electron from the reductase; (3) dioxygen binding to the ferrous protein, thus giving the 
ferrous-dioxygen complex, which can also be written as a resonance form, ferric- 
superoxide; (4) transfer of the second electron, which may come via the reductase or, in 
some instances, from ferrous cytochrome b,; (5) splitting of the oxygen-oxygen bond to 
yield H 2 0  and a postulated iron-oxene species; ( 6 )  hydrogen abstraction from the 
substrate to give a transient substrate carbon radical and an iron-bound hydroxyl 
radical or equivalent, as proposed by Groves et aE2' on the basis of the intramolecular 
isotope effect observed with deuteronorbornane; and (7) radical recombination 
followed by (8) dissociation from the enzyme of the resulting product, ROH. Thus, the 
resting ferric state of the enzyme is regenerated prior to another cycle. The reactions 
proposed are compatible with the known stoichiometry of the hydroxylation reac- 
tion:" 
RH + O2 + NADPH + H' - ROH + HzO + NADP+ 
An interesting variation is now recognized in which a peroxy compound (XOOH), 
RH 
FIGURE 2. Electron transfer reactions in the microsomal P-450 system. 
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ROH RH 
FIGURE 3. Proposed scheme for mechanism of action of cytochrome P-450 in hydroxylation 
reactions, taken from reference 8. RH represents a substrate and ROH represents the correspond- 
ing product. 
which may be hydrogen peroxide or an organic peracid or hydroperoxide, provides the 
oxygen atom in a reaction not requiring molecular oxygen, NADPH, or the 
r e d ~ c t a s e : ~ ~  
RH + XOOH - ROH + XOH 
Clearly, variations on this scheme are required to account for the mechanism of 
other reactions involving P-450, in processes as diverse as dehalogenation and 
desulfuration. 
MULTIPLICITY OF P-450 ISOZYMES 
As reviewed e l ~ e w h e r e , ’ ~ ~ ~ . ~ ~  the total number of mammalian P-450 isozymes is 
large, but not yet known exactly, and they appear to fall into two large groups: those 
concerned primarily with lipid metabolism, and those having very broad substrate 
specificity and acting both on lipids and foreign compounds. The latter type, which is 
found in hepatic microsomes, includes those P-450 cytochromes that were the first to 
be purified to homogeneity and characterized biochemically. For example, the 
presently known isozymes from rabbit liver microsomes are  shown in TABLE 1 .  Since 
the discovery and determination of the properties of a number of these has already been 
re~iewed, ’ .~~ .~’  only more recent developments will be emphasized here. Isozyme 1 has 
been obtained from uninduced animals,26 isozyme 3a from alcohol- and imidazole- 
induced animals27s2* (and, apparently, also after benzene treatment29), and isozyme 5 
from lung30 (corresponding to a form in liver”); in addition, the polymorphism of 
isozyme 3b has been d e m ~ n s t r a t e d . ~ ~  Furthermore, Wikvall and associates” have 
purified liver microsomal isozymes with the same electrophoretic behavior as isozyme 
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4,34 but apparently otherwise distinct, and they have also recently isolated a liver 
mitochondria1 P-450 with cholesterol 26-hydroxylase activity.)’ Some of the forms 
isolated by Sat0 and colleagues36 are believed to  be different from those studied in 
other laboratories; two of these are listed here as P-450, and P-450,, but it should be 
noted that in this case the nomenclature with substrates is not based on electrophoretic 
mobility. Many of these isozymes are active in the hydroxylation of testosterone and 
androstenedione in various positionsZ’ or of other steroids. 
P-450 isozyme 1 has been reported to have the highest activity of six rabbit liver 
cytochromes examined for the 21-hydroxylation of p r o g e s t e r ~ n e , ~ ~ * ~ ’  The purified 
enzyme has a minimal molecular weight of about 48,000 and exhibits a K ,  and V,,, for 
progesterone hydroxylation of 1.6 pM and 7.1 min-I, respectively, which are values 
very similar to those reported for the adrenal 21 -hydroxylase.’ However, unlike the 
adrenal enzyme, which hydroxylates only a t  the 21-position, isozyme 1 also hydroxy- 
lates at the 6@ and 16a positions of progesterone.’ In addition, this purified hepatic 
enzyme catalyzes the 2-hydroxylation of estradiol.” Whether the liver enzyme has 
TABLE 1. Rabbit Liver Microsomal Cvtochrome P-450 Isozvmes and Inducers 
lsozyme Inducer 
P-450 I 
P-450 2 Phenobarbital 




P-450 3~ Troleandomycin, erythromycin 
P-450 4 Isosafrole, P-naphthoflavone, 
P-450 (4) (Chol. 7a) 
TCDD, 3-methylcholanthrene 
Cholest yramine 
P-450 (4) (Chol. 12a) 
P-450 (4) (Chol. 26)  
P-450 5 Phenobarbital 
P-450 6 TCDD, imidazole 
P-450, 
P-4508 
extensive structural features in common with those of the adrenal microsomal enzyme 
and, furthermore, whether it provides a physiological pathway for the extra-adrenal 
production of hormones remains to be determined. 
Since a cysteine residue is known to provide the sulfur ligand to the heme iron atom 
in the P-450 cytochromes, as indicated above, it may be presumed that the cysteine 
peptide providing this function would be conserved during evolution. A comparison of 
three conserved cysteine peptides in various P-450 cytochromes is given in FIGURE 4, in 
which the areas of structural homology with respect to isozyme 4 are  enclosed in boxes. 
The P-450’s represented are rabbit isozymes 4” and 2,4OV4’ rat isozymes b,4z*43 c,- 
and d,”.“ mouse isozymes 1 and 3,49.s0 bacterial P-450,,,” and pig adrenal microsomal 
21-hydro~yIase.’~~~ The most extensive homology is seen with the cysteine near the 
COOH-terminus, which may possibly be the source of the sulfur ligand. Recent 
experiments in this laboratory (unpublished results, S. D. Black and M. J. Coon), in 
which rabbit isozyme 2 was treated with DTNB or monobromobimane appear to rule 
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T L L F H S I T S N I  
~~~ 
FIGURE 4. Comparison of the sequence of cysteine peptides in various P-450 cytochromes. 
Homology with respect to rabbit liver microsomal P-450 isozyme 4 is shown by the enclosed 
areas. 
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out Cys-152 as providing the sulfur ligand, but it may have some other function such as 
the binding of NADPH-cytochrome P-450 reductase. 
DISCUSSION 
Despite some differences in substrate specificity, the P-450 cytochromes are 
believed to be similar both in their ability to bind hydrophobic substrates and 
molecular oxygen at  the active site and in the manner in which they bring about the 
reductive activation of molecular oxygen, with one atom going to water and the other 
being inserted into the substrate. The activity of this family of enzymes in substrate 
monooxygenation varies in some instances with the age and sex of the animal, as well as 
with exposure to foreign chemicals. Indeed, with those P-450’s having broad substrate 
specificity, a myriad of physiologically occurring lipids and foreign compounds serves 
both as substrates and as mutually competitive inhibitors. The more specific, extrahe- 
patic steroid-hydroxylating cytochromes are known in some instances to oxygenate 
certain xenobiotics as well, but the possibility has not been studied adequately as to 
whether those xenobiotics that are not oxygenated at  a significant rate are nevertheless 
bound at  the active site and, thus, serve as nonmetabolizable, competitive inhibitors. 
Thus, an enormous variety of foreign organic compounds in our environment 
(estimated to be at  least 100,000 in technologically advanced countries) could play an 
indirect role in adrenal hyperplasia. Exposure to foreign compounds, including ethanol, 
food additives, insecticides, dyes, combustion products, solvents, and so forth, may 
occur both pre- and postnatally. The P-450 system is also sensitive to dietary 
alterations, not only because of the need for vitamins and other building blocks in the 
biosynthesis of NADPH, flavins, heme, and proteins, but also because the integrity of 
biological membranes in which these enzymes are  embedded is subject to nutritional 
 influence^.^^ ’’ Thus, genetic control of the 21-hydroxylase and other steroid hormone- 
metabolizing P-450’s could be modified by environmental factors. 
SUMMARY 
The P-450 cytochromes have been characterized biochemically in recent years as a 
family of monooxygenases that reductively activate molecular oxygen for insertion into 
steroids and other physiologically occurring lipids. Many of these enzymes are also 
known to bind and oxygenate a host of foreign compounds, including alcohol, drugs, 
pesticides, anesthetics, and mutagens. Some of the poorly understood variations in 
congenital adrenal hyperplasia may represent nutritional effects on the P-450 
oxygenase systems or the ability of xenobiotics to interfere with normal steroid 
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